These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 3519939)
1. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939 [TBL] [Abstract][Full Text] [Related]
2. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550 [TBL] [Abstract][Full Text] [Related]
3. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo. Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620 [TBL] [Abstract][Full Text] [Related]
4. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor. Michael-Titus A; Preterre P; Giros B; Costentin J J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843 [TBL] [Abstract][Full Text] [Related]
5. Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens. Blum K; Wallace JE; DeLallo L; Briggs AH Funct Neurol; 1986; 1(2):156-64. PubMed ID: 3301556 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase A. Chipkin RE; Iorio LC; Barnett A; Berger J; Billard W Adv Biochem Psychopharmacol; 1982; 33():235-42. PubMed ID: 6751031 [No Abstract] [Full Text] [Related]
7. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe. De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility). Nabeshima T; Katoh A; Kameyama T J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats. Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364 [TBL] [Abstract][Full Text] [Related]
11. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats. Bousselmame R; Eustache M; Michael-Titus A; Costentin J Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043 [TBL] [Abstract][Full Text] [Related]
12. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro. Adjroud O J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan. Livingston SJ; Sewell RD; Rooney KF; Smith HJ Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801 [TBL] [Abstract][Full Text] [Related]
14. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep. Rivière PJ; Buéno L Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911 [TBL] [Abstract][Full Text] [Related]
15. Analgesia after inhibition of enkephalin degradation. Kehl LJ J Am Dent Assoc; 1986 Feb; 112(2):181-3. PubMed ID: 2419379 [No Abstract] [Full Text] [Related]
16. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan. Chipkin RE; Latranyi MZ; Iorio LC; Barnett A Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic. Chipkin RE; Berger JG; Billard W; Iorio LC; Chapman R; Barnett A J Pharmacol Exp Ther; 1988 Jun; 245(3):829-38. PubMed ID: 3164388 [TBL] [Abstract][Full Text] [Related]
19. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme]. Roques BP J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752 [TBL] [Abstract][Full Text] [Related]
20. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity. Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]